← Eichor
Study identifier: NCT07029451 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

To Investigate REKOVELLE in Chinese Women Undergoing Assisted Reproductive Technologies: Effectiveness, Safety, and Patterns of Use in Real-world Practice

Condition: Infertility  ·  Sponsor: Ferring Pharmaceuticals

PhaseN/A
Planned participants2500
Who can joinFemale, 20 Years to no upper limit
Healthy volunteersNo

About this study

This is a multi-centre prospective non-interventional trial to assess the pattern of use of REKOVELLE® in Women Undergoing In Vitro Fertilisation (IVF) or Intracytoplasmic Sperm Injection (ICSI) Procedures in Routine Clinical Practice. There will be approximately 2500 patients initiated with REKOVELLE® treatment and enrolled in 30-50 sites in China. The total duration of the study will be approximately 35 months.

This description comes directly from the study's public registry record.

Talk to the study team

Global Clinical Compliance  ·  +1 862-286-5200  ·  Disclosure@ferring.com

Always discuss trial participation with your own doctor first.

Locations (28)

The First Affiliated Hospital of Anhui Medical UniversityHefei, Anhui, ChinaRecruiting
Maanshan Maternal and Child Health Care HospitalMa’anshan, Anhui, ChinaRecruiting
Beijing Obstetrics And Gynecology Hospital Capital Medical UniversityBeijing, Beijing Municipality, ChinaRecruiting
Beijing Chaoyang Hospital (Beijing)Chaoyang, Beijing Municipality, ChinaRecruiting
Peking University First HospitalXicheng, Beijing Municipality, ChinaRecruiting
6th Affiliated Hospital of Sun Yat Sen UniversityGuangzhou, Guandong, ChinaRecruiting
3rd Affiliated Hospital of Guangzhou Medical University (Guangzhou)Guangzhou, Guangdong, ChinaRecruiting
The First Affiliated Hospital of Shantou University Medical CollegeShantou, Guangdong, ChinaRecruiting
The Second Nanning People's HospitalNanning, Guangxi, ChinaRecruiting
Tongji Hospital Tongji Medical College of HustWuhan, Hubei, ChinaRecruiting
Hubei Maternal and Child Health HospitalWuhan, Hubei, ChinaRecruiting
Reproductive & Genetic hospital Of CITIC-XiangyaChangsha, Hunan, ChinaRecruiting

+ 16 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07029451